Matches in Wikidata for { <http://www.wikidata.org/entity/Q66041063> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66041063 description "clinical trial" @default.
- Q66041063 description "ensayu clínicu" @default.
- Q66041063 description "klinisch onderzoek" @default.
- Q66041063 description "клінічне випробування" @default.
- Q66041063 name "A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease" @default.
- Q66041063 name "A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease" @default.
- Q66041063 type Item @default.
- Q66041063 label "A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease" @default.
- Q66041063 label "A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease" @default.
- Q66041063 prefLabel "A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease" @default.
- Q66041063 prefLabel "A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease" @default.
- Q66041063 P1132 Q66041063-91307C4F-2510-482E-B60C-BE876CFAAD32 @default.
- Q66041063 P1476 Q66041063-A36824CD-57BB-4F70-AC79-2BE5382A8144 @default.
- Q66041063 P17 Q66041063-E0511E5E-F3B6-4798-A81E-7A1BDE69A998 @default.
- Q66041063 P2899 Q66041063-218AE2BB-5B9E-4856-8993-A2419EE72619 @default.
- Q66041063 P3098 Q66041063-70A2D6FA-B16B-452E-8251-E60E54055AA1 @default.
- Q66041063 P31 Q66041063-0A833BB9-B72D-4D02-80A5-B02BB70311B1 @default.
- Q66041063 P4844 Q66041063-5AF091A7-47B0-48DA-ABFD-9D5C18110044 @default.
- Q66041063 P4844 Q66041063-A54305A9-0D26-45C0-8672-58AC9AFAB8C5 @default.
- Q66041063 P6099 Q66041063-7B0B5B7D-C627-4C87-A7B8-E1477F9F852D @default.
- Q66041063 P6153 Q66041063-03DB4E96-7F94-4778-A991-A33B9838E2A0 @default.
- Q66041063 P767 Q66041063-6EEE5F60-DCD3-45CE-AB73-9BF54BAFA5CD @default.
- Q66041063 P8363 Q66041063-0DF7AF18-6924-4CE3-8EF7-9F58D3678BEB @default.
- Q66041063 P1132 "+116" @default.
- Q66041063 P1476 "A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease" @default.
- Q66041063 P17 Q30 @default.
- Q66041063 P2899 "+12" @default.
- Q66041063 P3098 "NCT00000656" @default.
- Q66041063 P31 Q30612 @default.
- Q66041063 P4844 Q198504 @default.
- Q66041063 P4844 Q422606 @default.
- Q66041063 P6099 Q5452194 @default.
- Q66041063 P6153 Q235034 @default.
- Q66041063 P767 Q266423 @default.
- Q66041063 P8363 Q78089383 @default.